Baylor College of Medicine-Houston Methodist & Texas Children's Hospital

Houston, Texas 77030

0 studies enrolling now · 1 studies all time

What they study most

Steroid-refractory Acute Graft-versus-Host Disease, Treatment-refractory Acute Graft-versus-Host Disease

Studies at this site

• Neihulizumab (ALTB-168) in Patients With Steroid-refractory Acute Graft-versus-host Disease or Treatment-refractory Acute Graft-versus-host Disease — Completed